(2026). FREM1 promotes anlotinib resistance in non-small cell lung cancer through regulation of extracellular matrix organization. Discover Oncology.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"FREM1 Promotes Anlotinib Resistance in Non-small Cell Lung Cancer Through Regulation of Extracellular Matrix Organization."
Discover Oncology 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"FREM1 Promotes Anlotinib Resistance in Non-small Cell Lung Cancer Through Regulation of Extracellular Matrix Organization."
Discover Oncology, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.